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Cyclic di-adenosine monophosphate (c-di-AMP) is a
broadly conserved second messenger required for
bacterial growth and infection. However, the mole-
cular mechanisms of c-di-AMP signaling are still
poorly understood. Using a chemical proteomics
screen for c-di-AMP-interacting proteins in the path-
ogen Listeria monocytogenes, we identified several
broadly conserved protein receptors, including the
central metabolic enzyme pyruvate carboxylase
(LmPC). Biochemical and crystallographic studies
of the LmPC-c-di-AMP interaction revealed a previ-
ously unrecognized allosteric regulatory site 25 A˚
from the active site. Mutations in this site disrupted
c-di-AMP binding and affected catalytic activity of
LmPC as well as PC from pathogenic Enterococcus
faecalis. C-di-AMP depletion resulted in altered
metabolic activity in L. monocytogenes. Correction
of this metabolic imbalance rescued bacterial
growth, reduced bacterial lysis, and resulted in
enhanced bacterial burdens during infection. These
findings greatly expand the c-di-AMP signaling
repertoire and reveal a central metabolic regulatory
role for a cyclic dinucleotide.
INTRODUCTION
The colonization of diverse environmental and host niches by
bacteria depends on the ability to sense and respond to
external stimuli. Signal transduction pathways dependent
upon nucleotide-based second messengers are ubiquitousCamong bacteria (Kalia et al., 2013) and mediate cellular devel-
opment, group behavior, and metabolism as a result of chang-
ing environmental conditions. Among such molecules, cyclic
di-adenosine monophosphate (c-di-AMP, cdA) has recently
emerged as a broadly conserved second messenger of fun-
damental importance for microbial growth and physiology,
with effects on stress responses, antibiotic resistance, cellular
morphology, bacterial growth, and virulence (Campos et al.,
2014; Corrigan et al., 2011; Corrigan et al., 2013; Luo and Hel-
mann, 2012; Mehne et al., 2013; Oppenheimer-Shaanan et al.,
2011; Pozzi et al., 2012; Smith et al., 2012; Witte et al., 2013;
Zhang and He, 2013). Moreover, c-di-AMP secreted by
L. monocytogenes, M. tuberculosis, and C. trachomatis during
infection results in an IFN-b-mediated host immune response
(Barker et al., 2013; Woodward et al., 2010; Yang et al.,
2014). Together, these reports have established c-di-AMP
as a crucial intracellular signaling molecule and an impor-
tant component of innate immune detection during infection.
Despite this central importance, the molecular mechanisms
of c-di-AMP-mediated signal transduction in bacteria are just
being elucidated.
Components of second messenger signaling systems in-
clude mechanisms to generate, degrade, and relay the signal.
C-di-AMP is synthesized from two molecules of ATP (Witte
et al., 2008), and in some cases ADP (Bai et al., 2012), through
the catalytic activity of di-adenylate cyclases (DACs). The
signal is subsequently degraded to pApA or AMP by DHH/
DHHA1 domain containing phosphodiesterases (Bai et al.,
2013; Rao et al., 2010). Second messengers initiate signal
transduction by binding to and altering protein and nucleic
acid function, resulting in transcriptional, translational, and
posttranslational alterations within a cell. Recent reports have
identified several mechanisms of c-di-AMP regulation within
these contexts, including riboswitches and protein receptorsell 158, 1389–1401, September 11, 2014 ª2014 Elsevier Inc. 1389
Figure 1. Identification of c-di-AMP-Inter-
acting Proteins from L. monocytogenes
(A) Schematic diagram of chemical proteomics
used to identify c-di-AMP-interacting proteins. 1
and 2 represent direct and indirect specific
binding proteins.
(B) Representative pull-down from bacterial ly-
sates with c-di-AMP (+) and control sepharose ().
The remaining lanes from the SDS-PAGE gel have
been removed for clarity.
(C) Quantitative shotgun proteomics of c-di-
AMP-binding proteins. Data are sorted based
upon fold change (FC) in spectral count ratio
(c-di-AMP sepharose/control sepharose). Data
points in red represent proteins with FC > 7
(horizontal black line) and a false discovery rate
(FDR) < 0.05.
(D) List of top hits identified by chemical
proteomics. Studies performed in L. mono-
cytogenes strain 10403S. Locus numbers based
on strain EGD-e (Accession number: NC_
003210.1).
(E and F) Proteins in bold confirmed for direct c-di-
AMP binding with (E) purified recombinant pro-
teins or (F) crude cell lysate for proteins identified
by chemical proteomics.
Data are mean ± SEM and are representative of
multiple independent experiments. *p < 0.05
(Students t test, two-tailed). See also Figure S1,
S2, and S3.(Bai et al., 2014; Corrigan et al., 2013; Nelson et al., 2013;
Zhang et al., 2013). However, c-di-AMP riboswitches are ab-
sent in some organisms and protein receptor homologs are
not well conserved. Similarly, the functional roles of identified
protein receptors cannot explain the breadth of phenotypes
associated with altered c-di-AMP levels. Together these ob-
servations imply that additional c-di-AMP signaling pathways
likely exist.
Listeria monocytogenes is a gram-positive intracellular bacte-
rial pathogen that provides an attractive model to interrogate
the molecular details of protein-mediated c-di-AMP signaling.
C-di-AMP produced from a single DAC containing protein is a
central regulator of numerous fundamental processes within
this organism, including growth, cell wall homeostasis, stress
responses, and the establishment of infection (Witte et al.,
2013). In this study we developed a chemical proteomics
approach to identify the c-di-AMP-interacting proteins. We iden-
tified several c-di-AMP-binding proteins that are broadly
conserved in numerous bacterial species. Among these pro-
teins, we structurally and biochemically characterized the inter-
action with pyruvate carboxylase (PC) and characterized the
consequences of c-di-AMP regulation of central metabolic activ-
ity on L. monocytogenes survival within the host environment.
Our findings provide insight into the central biological function
of c-di-AMP among the diverse bacteria known to generate
this second messenger.1390 Cell 158, 1389–1401, September 11, 2014 ª2014 Elsevier Inc.RESULTS
Chemical Proteomics to Define the c-di-AMP
Interactome of L. monocytogenes
We utilized a proteomics approach to identify the c-di-AMP
interactome of L. monocytogenes (Figure 1A). The nucleotide
was covalently conjugated to epoxy-activated sepharose
beads (Figure S1). Nucleotide-bound and control beads were
used in parallel for affinity purification of proteins from
L. monocytogenes 10403S. Initial binding results were visually
analyzed by SDS-PAGE (Figure 1B) and subsequently using
gel-free quantitative shotgun proteomics (Figure 1C). We iden-
tified 12 proteins that were statistically significant among rep-
licates (false discovery rate < 0.05) and enriched > 7-fold by
spectral count ratio (>2 SD) with c-di-AMP versus control se-
pharose (Figure 1D). The four proteins with highest enrichment
are of conserved hypothetical annotation, with homologs
found in a large number of bacteria. Among these, the homo-
log of Lmo2692 in S. aureus was recently identified as a c-di-
AMP-binding protein (Corrigan et al., 2013). In addition, the
known c-di-AMP phosphodiesterase PdeA (Lmo0052) is the
fifth protein on our list (Witte et al., 2013). The successful iden-
tification of known c-di-AMP-binding proteins validated our
approach.
To confirm these interactions, proteins were probed for direct
c-di-AMP-binding by differential radial capillary action of ligand
Figure 2. LmPC Specifically Binds and Is
Inhibited by c-di-AMP.
(A) Binding titration of c-di-AMP and LmPC using
32P-c-di-AMP.
(B) Enzymatic activity of LmPC in the presence of
Acetyl-CoA (100 mM), varied pyruvate, and c-di-
AMP concentrations as indicated.
(C) Rate constants of pyruvate turnover in the
presence of c-di-AMP.
(D) Enzymatic activity of LmPC in the presence of
pyruvate (20 mM), varied Acetyl-CoA (allosteric
activator) and c-di-AMP concentrations as indi-
cated.
(E) LmPC activity in the presence of nucleotide
analogs. Data reported as percent activity relative
to that without added nucleotide. All data reported
as the mean ± SEM and are representative of
multiple independent experiments. See also
Figure S4.assay (DRaCALA) (Roelofs et al., 2011). 32P-labeled c-di-AMP
was synthesized (Figure S2) and used to quantify binding.
Those proteins predicted to be soluble by in silico analysis
(Bernsel et al., 2009) were expressed and purified to homoge-
neity from E. coli. The three soluble proteins of conserved hypo-
thetical annotation (renamed here PstA, CbpA, and CbpB)
as well as PdeA and LmPC exhibited binding in purified form
(Figure 1E). No binding was observed for purified recombinant
ClpC, OppA, CtaP, or Lmo1634, which were likely identified
because they interact with a direct c-di-AMP-interacting protein
(labeled 2 in Figure 1A) or contain posttranslational modifica-
tions that facilitate c-di-AMP binding. NrdR exhibited significant
instability in purified form, while Lmo1466 and NADH dehy-
drogenase are predicted to be membrane anchored. As
such, these proteins were characterized in whole-cell lysates.
E. coli lysates containing either an empty vector or encoding
Lmo0553 were used as negative and positive controls, respec-
tively (Figure 1F). A significant level of binding was observed for
Lmo1466 and NrdR-expressing lysates, consistent with a direct
interaction with c-di-AMP. No interaction was observed for ly-
sates derived from E. coli expressing NADH dehydrogenase.
However, overexpression of NADH dehydrogenase was not
observed and the direct interaction with c-di-AMP was there-
fore inconclusive.Cell 158, 1389–1401, SepThe top three proteins that displayed
positive binding and could be purified
were investigated in further detail.
CbpA, CbpB, and PstA demonstrated
c-di-AMP-binding constants <10 mM
(Figure S3), consistent with levels of
c-di-AMP reported in bacteria (Corrigan
et al., 2011). Specificity of the c-di-
AMP interaction was studied by com-
petitive binding with cold nucleotides.
For the proteins CbpA, CbpB, and
PstA, only excess c-di-AMP could abro-
gate binding when present at 400 mM
of unlabeled competing nucleotide (Fig-ure S3). These observations support a specific interaction
with c-di-AMP.
C-di-AMP is an Allosteric Inhibitor of LmPC
Among those newly identified c-di-AMP-binding proteins, only
LmPC (120 kDa) has a known biological function. In fact,
LmPC is essential for L. monocytogenes growth (Scha¨r et al.,
2010). Therefore, we focused our initial studies on the detailed
characterization of this molecular interaction and its biological
consequences. PC is a multidomain enzyme that catalyzes the
ATP-dependent carboxylation of pyruvate to oxaloacetate. Dur-
ing catalysis, the biotin carboxyl carrier protein (BCCP) domain is
carboxylated in an ATP-dependent manner by the biotin carbox-
ylase (BC) domain. Subsequently, the carboxyltransferase (CT)
domain mediates transfer of the carboxyl from biotin to the sub-
strate pyruvate. The PC tetramerization (PT) domain is important
for the quaternary structure of the enzyme (St Maurice et al.,
2007; Xiang and Tong, 2008) and together with the BC domain
defines the binding site of the allosteric activator acetyl-CoA
(St Maurice et al., 2007; Yu et al., 2009).
Binding studies indicated that LmPC interacts with c-di-AMP
with a Kd of 8 ± 0.2 mM (Figure 2A). We observed diminished
PC activity in the presence of increasing concentrations of c-
di-AMP (Ki 3 mM, Figure 2B). The inhibitory effect was at thetember 11, 2014 ª2014 Elsevier Inc. 1391
Figure 3. Crystal Structure of LmPC in Complex with c-di-AMP
(A) Omit Fo–Fc electron density map for c-di-AMP at 2.5 A˚ resolution, contoured at 3s.
(B) Schematic drawing of the structure of LmPC tetramer in complexwith two c-di-AMPmolecules. The domains of monomer 1 are colored separately, according
to the diagram at the bottom of the panel. c-di-AMP is shown as a sphere model and labeled cdA (carbon atoms in black). Themetal ion in the active site of the CT
domain is shown as a gray sphere and labeled M2+. The distance from the CT active site and c-di-AMP-binding site is indicated with the dashed red line.
(C) Detailed interactions between c-di-AMP and LmPC. Hydrogen-bonding interactions are indicated with dashed lines (in red). Water molecules are shown as
red spheres. All structure figures were produced with PyMOL (www.pymol.org).
See also Table S1 and Figure S5.level of the apparent kcat with slight lowering of the apparent Km
(Figure 2C), indicating that c-di-AMP does not compete with the
pyruvate substrate. We also found that the inhibition by c-di-
AMP could be overcome by high concentrations of acetyl-CoA
(Figure 2D). Finally, the inhibition was specific to c-di-AMP as
most of structurally related dinucleotides (Figure S4), includ-
ing c-di-GMP, bacterial cGAMP (cyclic[Gp(30,50)Ap(30,50)]), or
pApA, the breakdown product of c-di-AMP, showed no effect
on LmPC activity, while c-di-IMP did show weak inhibitory
activity (Figure 2E). Overall, these biochemical studies define
c-di-AMP as an allosteric inhibitor of LmPC.
Binding Mode of c-di-AMP in LmPC
To understand themolecular basis for the enzyme regulation, we
determined the structure of the LmPC-c-di-AMP complex at
2.5 A˚ resolution (Table S1). Clear electron density was observed
for the c-di-AMP ligand based on the crystallographic analysis
(Figure 3A). Unexpectedly, we observed another c-di-AMP that
bridges two c-di-AMP molecules bound to neighboring LmPC
in this crystal (Figure S5A). The bridging c-di-AMP inserts one
of its adenine bases between the two bases of the bound c-di-
AMP, forming p-stacking interactions, but it has no direct
contacts with the protein (Figure S5A). We observed a second
crystal form of the complex from the same crystallization condi-1392 Cell 158, 1389–1401, September 11, 2014 ª2014 Elsevier Inc.tion, and determined its structure at 2.7 A˚ resolution (Table S1).
The bridging c-di-AMP molecule is absent in this crystal (Fig-
ure S5B), but the structure of the complex is essentially identical
to the other crystal form (Figure S5C). Therefore, the bridging
c-di-AMP is most likely an artifact in that crystal form and will
not be discussed further. A citrate molecule was found in the
acetyl-CoA-binding site, although our kinetic studies showed
that citrate had only small effects on the catalytic activity of
LmPC. Its presence in the structure was likely due to the high
concentration in the crystallization solution.
LmPC is a tetramer in the crystal structure (Figures 3B and
S5C), consistent with solution studies as well as earlier struc-
tures of R. etli PC (RePC), S. aureus (SaPC), and H. sapiens
(HsPC) (St Maurice et al., 2007; Xiang and Tong, 2008). The
tetramer is composed of two layers, with two monomers in
each layer. There are extensive interactions between the two
layers, mediated through the BC and CT domain dimers, which
are located at opposing corners of the diamond-shaped
tetramer. In contrast, there are few direct contacts between
the two monomers in the same layer. All four BCCP domains
are observed, but the linkers between the PT and the BCCP do-
mains (residues 1060–1066) are disordered. As a result, each
BCCP domain is assigned to a monomer based on the earlier
structure of SaPC (Figure 3B), although the actual PT-BCCP
connectivity is ambiguous in LmPC. The overall position of
BCCP is similar to that in the exo site of the SaPC structure
(Xiang and Tong, 2008), but its orientation is very different (Fig-
ure S6A). Consequently, the biotin group in the current structure
is projected into the solvent and disordered. Besides the PT-
BCCP linker, the B domain of BC (residues 135–205) is also
disordered in the crystals.
The c-di-AMP nucleotide is bound at the dimer interface of two
CT domains (Figures 3B), with the 2-fold symmetry axis of the
compound aligned with that of the CT domains (Figure 3C).
Therefore, each LmPC tetramer binds only two c-di-AMP mole-
cules (Figure 3B). The binding site is formed by two helices in the
TIM barrel fold of the CT domain (Figure 3C), but it is located
25 A˚ away and on the opposite face from the CT active site
(Figures 3B). This region of PC has not been known previously
to have any regulatory or structural significance.
The c-di-AMP ligand adopts a U-shaped conformation (Fig-
ure 3A) and interacts with LmPC through hydrophobic and
hydrogen-bonding interactions (Figure 3C). The aromatic ring
of Tyr722 has a direct face-to-face p-stacking arrangement
with an adenine base. One of the terminal oxygen atoms of the
phosphate group of c-di-AMP forms a hydrogen bond with the
hydroxyl group of Tyr749, while the other terminal oxygen inter-
acts with the Ser756 side chain through a water molecule. The
ribose is located near Ala753, which together with Ala752 may
provide the space necessary for the ligand to bind.
The U-shaped conformation of c-di-AMP is similar to the bind-
ing mode of c-di-GMP in some proteins, such as the bacterial
PilZ domain (Benach et al., 2007) and the human STING protein
(Huang et al., 2012; Ouyang et al., 2012; Shang et al., 2012; Shu
et al., 2012; Yin et al., 2012). In addition, c-di-GMP is also aligned
with the 2-fold symmetry axis of a STING dimer, and the guanine
base isp-stackedwith a Tyr side chain. Together these observa-
tions identify a binding site of c-di-AMP to LmPC and confirm
kinetic studies that the site is unique from known substrates or
allosteric regulators of this family of enzymes.
The c-di-AMP-Binding Site Affects PC Catalytic Activity
To assess the functional importance of the binding site, we intro-
duced amino acid mutations into LmPC. We noted conservation
of ap-stacking aromatic amino acid amongmany cyclic dinucle-
otide-binding proteins, including STING, VpsT, and the EAL
domain protein YahA (Huang et al., 2012; Krasteva et al., 2010;
Ouyang et al., 2012; Shang et al., 2012; Sundriyal et al., 2014;
Yin et al., 2012), implicating Y722 as a critical residue for nucle-
otide recognition. Two amino acid substitutions (Y722F and
Y722T) were introduced into this site. The Y722F mutant was
chosen to assess the importance of the hydroxyl group interact-
ing with the N6 of the adenine base. The Y722T mutant was cho-
sen due to the presence of this amino acid in the corresponding
site of HsPC (Figure 4A). Comparison of the LmPC and SaPC
structures revealed that the analogous binding pocket does
not apparently exist within the latter enzyme (Figures 4B, 4C,
S6A, and S6B). This can be attributed to the presence of a Lys
and Gln substitution in SaPC corresponding to A752 and A753
of LmPC, respectively, which introduce significant steric bulk
into the pocket. Similarly, the Y749 residue required for hydrogen
bonding to the terminal oxygen of the phosphate at the bottom ofCthis pocket has been lost. These observations were used to
guide amino acid substitutions in the LmPC protein.
The mutants were expressed and purified following the same
protocol as was used for the wild-type protein. All amino acid
mutants, except Y749L, were catalytically active. However, the
Y722T, A752K, and A753Q variants lost sensitivity to inhibition
by c-di-AMP even at 100 mM concentration (Figure 4D). Interest-
ingly, the enzyme activity in the absence of c-di-AMP was sub-
stantially different from WT, with both increased and reduced
activity being observed for the mutants, suggesting that this re-
gion of the enzyme has a functionally relevant effect on PC catal-
ysis. The Y722F mutant behaved similar to the wild-type enzyme
in terms of its catalytic activity and responsiveness to c-di-AMP,
establishing that the hydroxyl group of Y722 is dispensable for
nucleotide recognition. In agreement with the kinetic data, bind-
ing to c-di-AMP was only observed for Y722F and none of the
other amino acid variants (Figure 4E).
We noted that although several of the residues required for
c-di-AMP binding by LmPC are absent in other bacterial en-
zymes, the required chemical features of the binding pocket
might be conserved. Specifically, when comparing LmPC to
PC from lactic acid bacteria (Figure 4A), such as PC from the
opportunistic pathogen Enterococcus faecalis (EfPC), structural
modeling predicted that the A752S and S756K variants could
establish favorable interactions with the c-di-AMP phosphate
group and compensate for the loss of the Y749 residue (Figures
4F–4G). Indeed, recombinant EfPC binds c-di-AMP and its cat-
alytic activity is inhibited by the nucleotide (Figures 4G and
4H). Consistent with a conserved binding site between the en-
zymes, mutation of the base stacking tyrosine results in loss of
c-di-AMP binding and regulation. Similarly, SaPC is insensitive
to c-di-AMP. Overall, the results from these studies confirm
the c-di-AMP-binding site identified by the structural analysis
and identify a previously unrecognized region important for PC
regulation in L. monocytogenes and other bacteria.
C-di-AMP Binding Induces Large Conformational
Changes in LmPC
We have also determined the structure of apo LmPC (Table S1),
in the absence of c-di-AMP. The best quality X-ray diffraction
data set we could collect after screening through a large number
of crystals was at 3.3 A˚ resolution. There are two tetramers in the
asymmetric unit that have essentially the same conformation,
with root mean square (rms) distance of 0.1 A˚ among their equiv-
alent Ca atoms (NCS restraints were applied throughout the
refinement and the crystal had pseudo C2 space-group symme-
try). Therefore, only one of these tetramerswill be used for further
analysis. All four BCCP domains and residues 850–950 in the CT
domain of one of the monomers had poor electron density and
were not modeled. The B domain of BC was partially ordered
in the four monomers and there was weak density for an ATP
molecule.
A comparison of the structure of apo LmPC and that bound to
c-di-AMP showed dramatic rearrangements in the tetramer
upon ligand binding (Figure 5A). Near the c-di-AMP-binding
site, there are significant changes in the orientation and position
of the two CT domains of the dimer, corresponding to a rotation
of 4.5 for each CT domain (Figure 5B). As a consequence, theell 158, 1389–1401, September 11, 2014 ª2014 Elsevier Inc. 1393
Figure 4. Functional Analysis of the c-di-
AMP-Binding Site of PC
(A) Conservation of residues in the c-di-AMP-
binding site. The five residues in the binding site
are highlighted in red.
(B) Molecular surface of the LmPC-binding site for
c-di-AMP (labeled cdA), colored by the electro-
static potential (red: negative, blue: positive).
(C) Molecular surface of SaPC at the CT dimer
interface. The c-di-AMP molecule is shown as a
reference in stick models.
(D) Effects of c-di-AMP on the catalytic activity of
wild-type and mutant LmPC.
(E) C-di-AMP binding to WT and mutant LmPC
proteins measured by DRaCALA.
(F) LmPC c-di-AMP-binding pocket with corre-
sponding EfPC amino acid variations.
(G) Surface view of modeled EfPC.
(H) C-di-AMP binding to WT and Y718T EfPC.
(I) Activity of WT and Y718T EfPC in the presence
and absence of c-di-AMP.
Data are mean ± SEM (D, E, G, and H) and are
representative a multiple independent experi-
ments. See also Figure S6.
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Figure 5. Large Conformational Differences
in the Structure of apo LmPC
(A) Overlay of the structure of LmPC in complex
with c-di-AMP (in color) with that of apo LmPC (in
gray). The superposition was based on monomer
1. Large differences in the positions of the other
monomers are visible.
(B) Conformational differences in the c-di-AMP-
binding site in the structure of apo LmPC.
(C)Molecular surface of apo LmPC at the CT dimer
interface. The c-di-AMP molecule would clash
with the enzyme in this conformation.
(D) Overlay of the four monomers of the LmPC
tetramer in the complex with c-di-AMP. The su-
perposition is based on the CT domain only. A
small conformational difference is seen for the BC
domain.
(E) Overlay of the four monomers of the apo LmPC
tetramer. Large differences are observed in the
positions and orientations of the BC domains.side chains of both Tyr722 and Ser756 in the apo enzyme would
clash with the c-di-AMP molecule in the complex. These
changes greatly reduce the size of the pocket in this region,
such that it can no longer accommodate c-di-AMP (Figure 5C).
The BC dimer in apo LmPC has roughly the same structure as
that in the complex with c-di-AMP (Figure S5D). However, the
position and orientation of the BC domain relative to the CT
domain are different between the apo enzyme and the c-di-
AMP complex. In addition, the four LmPC monomers in the
c-di-AMP complex have essentially the same conformation,
while the monomers in the apo enzyme have large structural dif-
ferences. This is best visualized by overlaying the CT domains of
the four monomers in each structure. For the c-di-AMP complex,
overlaying the CT domains essentially brought the BC and PT
domains into overlay as well, with a difference of only1 in their
orientations (Figure 5D). In comparison, the four monomers differ
by 10 in the orientations of their BC domains after the CTCell 158, 1389–1401, Sepdomains are overlaid for the apo enzyme,
and the hinge rotation is located near the
boundary between the BC and PT do-
mains (Figure 5E). In comparison, the
overlay of the CT domains brought the
PT domains into superposition. The PT
domains of SaPC and HsPC have impor-
tant roles in mediating contacts in the
tetramer (Xiang and Tong, 2008). The PT
domains in the c-di-AMP complex of
LmPC and apo LmPC are positioned
further away from each other and do not
make direct contacts (Figure 5A).
Metabolic Balance Mediated by
c-di-AMP Affects Intracellular
Growth of L. monocytogenes
Structural and biochemical character-
ization of the interaction between
LmPC and c-di-AMP implicates the
nucleotide as a metabolic regulator inL. monocytogenes. Listeria species have an incomplete citric
acid cycle, and the oxaloacetate (OA) generated by LmPC is
used as a precursor for aspartate and glutamate biosynthesis
(Figure 6A) (Kim et al., 2006). To study the effects of c-di-AMP
levels on metabolism in L. monocytogenes, we measured in-
corporation of isotope label from U-13C-glucose into amino
acids alanine (Ala), aspartate (Asp), and glutamate/glutamine
(Glx) in both WT and a conditional depletion strain of DacA
(cDdacA), which exhibits diminished levels of c-di-AMP (Witte
et al., 2013). Bacteria with depleted c-di-AMP exhibited substan-
tially increased 13C incorporation into Glx relative to bacteria with
normal levels of the nucleotide (Figure 6B). De novo synthesis of
Glx is entirely dependent on LmPC activity in L. monocytogenes
(Scha¨r et al., 2010) and flux through the oxidative branch of the
citric acid cycle. To determine if these observations are a result
of PC activity directly, we generated a double conditional deple-
tion strain, cDdacA cDpycA, with IPTG inducible expression oftember 11, 2014 ª2014 Elsevier Inc. 1395
Figure 6. Metabolic Imbalance Specifically Alters L. monocytogenes Intracellular Growth
(A) De novo biosynthesis of amino acids and labeling patterns from 13C-glucose by L. monocytogenes. Dark spheres, 13C. Light spheres, natural abundance
carbon.
(B) 13C enrichment into Ala, Asp, and Glx from midexponential L. monocyotogenes strains.
(C) Magnitude of growth of L. monocytogenes strains in iBMMs. Data reported as the ratio of CFU recovered at 8 hpi relative to 0.5 hpi.
(D) 13C enrichment into Ala, Asp, and Glx from midexponential L. monocyotogenes strains.
(E) Immortalized murine bone-marrow-derived macrophages were infected with L. monocytogenes and CFU were enumerated at the indicated times.
(F) Plaque area from mouse fibroblasts (L2 cells) infected with indicated strains and normalized to WT.
(G) Bacterial burden in organs 48 hr postinfection with the median indicated by a horizontal bar.
(C–F) Data aremean ±SEM (B–G) Data are representative of at least two independent experiments. (D) *p < 0.001 (Students t test, two-tailed). See also Figure S7.DacA and theophylline inducible expression of PC (Figure S7A).
Indeed, increased levels of theophylline in the absence of IPTG
led to a direct increase in Glx synthesis (Figure 6B). Thus, c-di-
AMP, through its action on LmPC and possibly other down-
stream targets that affect flux through this pathway, negatively
affects de novo Glx biosynthesis. In comparison, reduced c-di-
AMP levels did not affect Asp synthesis, indicating that LmPC
is not the limiting activity for this pathway.
We hypothesized that this metabolic imbalance may be
responsible for the defects in bacterial growth and host coloniza-
tion associated with low levels of c-di-AMP. To test this possibil-
ity we infected macrophages with the cDdacA cDpycA strain
grown in the presence of varying concentrations of theophylline.
Increased cytosolic growth was observed as theophylline levels
were increased until a critical threshold was achieved, after
which the strain exhibited limited growth comparable to cDdacA
(Figure 6C). These observations are consistent with previous
reports where low PC activity results in diminished bacterial
growth in the cytosol. However, our findings also show that
enhanced PC activity is detrimental in the absence of c-di-
AMP and are consistent with the requirement for balancedmeta-
bolic activity to establish infection in the host.
It has not been established why PC is essential for
L. monocytogenes, though disruption of aspB resulted in dimin-
ished bacterial growth (data not shown), consistent with this
being the essential branch emanating from the precursor metab-
olite oxaloacetate. Based on these observations, we hypothe-
sized that the metabolic imbalance associated with diminished1396 Cell 158, 1389–1401, September 11, 2014 ª2014 Elsevier Inc.c-di-AMP levels was a consequence of elevated flux to Glx. To
segregate the detrimental effects of hypo and hyperactive PC
we deleted citrate synthase (CitZ, Figure 6A), the first committed
step to Glx biosynthesis. Incorporation of 13C into Glx was abol-
ished in the WT and cDdacA strains containing the citZmutation
(Figure 6D), while levels of Asp and Ala incorporation remained
unchanged. Thus, disruption of citZ prevents unregulated gluta-
mate/glutamine biosynthesis from glucose under conditions of
low c-di-AMP.
Having corrected the elevated synthesis of Glx, we detailed
the effects of metabolic imbalance associated with altered
c-di-AMP signaling on L. monocytogenes growth and infection.
Although disruption of citZ had no discernable effect on broth
growth in the presence or absence of c-di-AMP production
(Figure S7B), a significant increase in intracellular growth in
the absence of c-di-AMP was observed within immortalized
bone-marrow-derived macrophages (iBMM) and mouse fi-
broblasts (Figures 6E and 6F). No change in growth was
observed for citZ disruption in the WT background (Figures
6F and S7C). Analysis of bacterial growth revealed that the
doubling time was not significantly altered by loss of citZ,
consistent with observations in rich media. However, the ability
of L. monocytogenes to maintain intracellular growth between 5
and 8 hr was rescued by disruption of citZ, resulting in nearly
WT levels of bacterial burden at later time points. Expression
of the citrate synthase gene in trans attenuated intracellular
growth of the cDdacA DcitZ strain back to cDdacA levels
(Figure 6E).
Figure 7. C-di-AMP-Induced Metabolic Imbalance Provokes Intra-
cellular Bacteriolysis and Host Cell Pyroptosis
(A) Cytotoxicity induced in iBMMs by the indicated strains following infection
was measured by LDH release.
(B) Intracellular lysis of bacterial strains in iBMMs as measured by reporter
plasmid delivery. Percent lysis was determined by normalizing to Holin-Lysin
and uninfected controls.
(C) Lysis of L. monocytogenes strains grown in BHI.
(D) Growth of cDdacA L. monocytogenes in WT (closed symbols) and Caspase
1/ (open symbols) BMMs.
Data are mean ± SEM and are representative of at least two independent
experiments. *p < 0.05 (Students t test, two-tailed); NS, not significant.To further characterize the effects of metabolic imbalance
associated with c-di-AMP deficiency, a murine model of acute
listeriosis was characterized. As previously reported (Witte
et al., 2013), the cDdacA strain exhibited 3.8- and 4.6-log defects
in both the spleen and liver, respectively (Figure 6G). When citZ
was disrupted in the cDdacA strain, 2.7- and 2.4-logs of growth
were rescued in the spleen and liver, respectively. Together
with ex vivo analysis of intracellular growth, these findings
support a model whereby metabolic imbalance associated
with altered c-di-AMP levels specifically affects the magnitude
of L. monocytogenes growth within the host cell cytosol with
significant consequences on bacterial virulence.
Metabolic Imbalance in L. monocytogenes Causes
Bacteriolysis within the Host Cytosol
To further elucidate the basis for the intracellular growth defect
resulting from altered bacterial metabolic activity, we charac-
terized the host response to infection. DNA released by
L. monocytogenes leads to activation of Caspase 1 through
the AIM2 inflammasome, resulting in pyroptosis during
L. monocytogenes infection (Sauer et al., 2010). We found that
bacteria with diminished levels of c-di-AMP production induce
increased cell death during infection (Witte et al., 2013), while
those with corrected metabolic activity through citZ disruption
exhibited significantly decreased levels of host cell death (Fig-Cure 7A). Consistent with these observations, bacteria deficient
in c-di-AMP production exhibit increased DNA delivery during
infection, while the metabolic correction of this strain results in
significantly reduced intracellular bacteriolysis (Figure 7B). Inter-
estingly, no significant change in bacteriolysis is observed during
growth in broth media (Figure 7C).
Pyroptosis is a protective host response to L. monocytogenes
infection (Sauer et al., 2011). As such, we predicted that removal
of this inflammatory response might rescue the growth of c-di-
AMP deficient bacteria that exhibit c-di-AMP-related metabolic
imbalance. Consistent with this hypothesis, intracellular growth
of bacteria deficient in c-di-AMP production significantly im-
proved in the absence of pyroptosis in primary bone-marrow-
derived macrophages (Figure 7D). These observations suggest
that the metabolic imbalance associated with diminished c-di-
AMP signaling leads in part to diminished bacterial growth as
a consequence of an enhanced restrictive host response.
Together with our biochemical studies we conclude that these
effects are most likely due to c-di-AMP-mediated regulation of
LmPC and perhaps other metabolic factors.
DISCUSSION
Chemical proteomics provides a powerful approach to interro-
gate small molecule-protein interactions (Rix and Superti-Furga,
2009). The nucleotide interactome revealed here substantially
broadens the known c-di-AMP protein-based signaling reper-
toire; identifying five previously unrecognized c-di-AMP-inter-
acting proteins in L. monocytogenes, in addition to LmPC.
The large number of effectors, their domain diversity, and seem-
ingly disparate functional roles (Grinberg et al., 2006; Leigh
and Dodsworth, 2007; Liu et al., 2006; Scott et al., 2004) are
consistent with the pleiotropic effects of the dacA gene in
L. monocytogenes.Our studies genetically segregate the effects
of c-di-AMP on the magnitude of intracellular growth and intra-
cellular bacterial lysis from other known phenotypes associated
with loss of c-di-AMP production. We anticipate that the identi-
fication of several other protein receptors for c-di-AMPwill guide
future studies to define the molecular details governing changes
in other c-di-AMP related phenotypes, including bacterial cell
stability in broth, susceptibility to cell-wall targeting antibiotics,
and bacterial growth rate in and out of the host.
Beyond broadening the known c-di-AMP effectors, our
studies provide a detailed molecular characterization of the ef-
fects of c-di-AMP on PC activity. Our structural studies of apo
and c-di-AMP-bound LmPC in comparison to known PC struc-
tures provide mechanistic insight into an unexpected mode
of enzyme regulation. The nearly identical structure of the
four LmPC monomers in the c-di-AMP complex is rather un-
usual among known PC structures. For SaPC, the differences
in the orientations of the BC domains vary between 6 and
18 after their CT domains are superimposed (Xiang and
Tong, 2008; Yu et al., 2009), and the differences are even larger
for RePC (St Maurice et al., 2007). The structural differences
among the four monomers in apo LmPC, as well as in SaPC
and RePC, indicate that domain movements are necessary dur-
ing PC catalysis, which is supported by recent EM studies on
SaPC (Lasso et al., 2014). Based on these observations, weell 158, 1389–1401, September 11, 2014 ª2014 Elsevier Inc. 1397
favor a mechanism whereby c-di-AMP ‘‘freezes’’ the enzyme
into a single (symmetrical) conformation, which is incompatible
with catalysis.
Structure-function studies also clearly establish the location
and strict specificity of the c-di-AMP-binding pocket. However,
it is currently not clear how nucleotide specificity is achieved,
as there are no hydrogen-bonding interactions to the base. Mu-
tations of the sole base-interacting amino acid, Tyr722, do not
extend inhibition activity to related nucleotides, and therefore
other residues may contribute to this specificity. Beyond confer-
ring specificity, changes in this pocket have significant conse-
quences on enzyme function, even in the absence of ligand
binding. These observations may be indicative of a previously
unrecognized allosteric site for PC enzymes in response to
c-di-AMP and possibly other stimuli. Significant variability is
observed within the regulatory site identified by our studies.
The EfPC-c-di-AMP interaction illustrates this mechanism of
regulation extends beyond L. monocytogenes and that in the
absence of amino acid conservation, divergent amino acids
within the c-di-AMP-binding site can compensate to maintain
nucleotide-mediated enzyme regulation. Given the central func-
tion of PC, proper integration of this enzyme into existing meta-
bolic networks is required to maintain metabolic balance. As
such, we postulate that the diversity of the sequence at this novel
functional site may reflect divergent mechanisms of regulation,
either through allosteric ligands or altered enzyme dynamics,
which fine tune activity such that PC can properly integrate
into the unique metabolic capacity of the diverse organisms
that utilize this enzyme.
Bacteria have the capacity to thrive within a variety of environ-
mental and host niches. This adaptability is largely reliant on
the capacity to utilize diverse nutrients encountered in these
disparate environments. The phosphoenolpyruvate-pyruvate-
oxaloacetate node of central metabolism shapes the distribution
of carbon metabolites among anabolic, catabolic, and energy-
producing pathways (Jitrapakdee et al., 2008; Jitrapakdee and
Wallace, 1999; Sauer and Eikmanns, 2005; Scha¨r et al., 2010).
Given this central function, aberrant metabolic activity as a
consequence of altered c-di-AMP signaling may disrupt any
one or a combination of the pathways required for bacterial
adaptation to accessible nutrients. During infection, intracellular
L. monocytogenes undergo a major metabolic transition from
utilization of glucose to alternative carbon sources (Joseph
et al., 2006), a process that affects activation of the master viru-
lence regulator PrfA (Joseph et al., 2008; Stoll et al., 2008).
Consequently, changes in PEP levels through increased pyru-
vate consumption may diminish PrfA activation and directly
link c-di-AMP-related metabolic activity to virulence capacity.
However, our observation that bacterial lysis is a downstream
consequence of altered c-di-AMP-dependent metabolism
suggests that the answer partially relates to the integrity of the
bacterial cell. The metabolic burden generated by unregulated
flux through the citric acid cycle may cause insufficiency in
cell wall biosynthesis intermediates, leading to bacteriolysis.
No apparent deficiency in de novo Asp, Ala, or Glx synthesis,
each of which contributes to biosynthesis of the glycan and pep-
tide components of the cell wall, suggests that limitations in
these metabolites are not responsible. As the critical compound1398 Cell 158, 1389–1401, September 11, 2014 ª2014 Elsevier Inc.utilized by L. monocytogenes to combat acid stress and the pri-
mary counter ion to osmotic stabilizing potassium (Booth and
Higgins, 1990; Cotter et al., 2005; Yan et al., 1996), synthesis
of glutamate must be tightly regulated to appropriately respond
to changing conditions. As such, increased production of
glutamate and the precursor metabolites in its biosynthetic
pathway may have toxic effects on bacterial stability in the
cytosol. Finally, hyperactivity of LmPC and subsequent turn-
over of OA by CitZ could lead to defects in lipid synthesis
by consuming acetyl-CoA, a major precursor for the acyl-chain
required to generate branched chain fatty acids. It is not known
if L. monocytogenes strains deficient in these lipids exhibit
enhanced intracellular lysis; however, the synthesis of these
membrane components is required for L. monocytogenes sur-
vival within the cytosol of the host cell (Sun and O’Riordan,
2010). Clearly the effects of PC regulation extend beyond this
intracellular pathogen. The evidence supporting PC regulation
among lactic acid bacteria suggests that both extracellular path-
ogenic (i.e., E. faecalis) as well as nonpathogenic commensal
Lactobacilli spp. utilize a similar mechanism of metabolic regula-
tion, though the effects of this regulation remain an open
question. Future studies to detail the functional consequences
of c-di-AMP-mediated metabolic regulation through PC and
likely other protein receptors will provide important insight into
the physiology of these medically important host associated
organisms.
In summary, the c-di-AMP-binding proteins reported here are
widespread and conserved among environmental and patho-
genic microbes alike and broadly expand the protein targets of
c-di-AMP in bacteria. Furthermore, our biochemical and struc-
tural studies may provide important insight into a new molecular
mechanism of central metabolic regulation through the enzyme
PC. Finally, our studies demonstrate that c-di-AMP signaling
regulates bacterial central metabolism and survival within the
host environment. These findings lead us to propose that c-di-
AMP serves a conserved and central role in the regulation of
fundamental metabolic processes with important physiological
implications in the unique environments occupied by the bacte-
ria that utilize this secondary signaling molecule. A detailed un-
derstanding of bacterial signaling and metabolic regulation has
profound practical and therapeutic applications. As a central
element of these processes, the possibility of targeting c-di-
AMP signaling pathways in this regard is an attractive option
that remains to be explored.EXPERIMENTAL PROCEDURES
C-di-AMP Pull-Downs
Soluble lysates from L. monocytogenes grown in 1.5 L BHI broth at 37C to
midexponential phase (OD600 = 0.8) were prepared in 30 ml of buffer (0.1 M
Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% v/v Tween-20, 1 mM PMSF). Lysates
were incubated with rotation for 2 hr at 4C with 100 ml ethanoamine or c-di-
AMP conjugated beads. Beads were washed three times with 5 ml PBS,
mixed with 100 ml of SDS-PAGE sample loading buffer, incubated at 56C
for 10 min, and the soluble fraction removed. The elution was repeated
and each was pooled and processed for quantitative mass spectrometry
as detailed in the Supplemental Information. Pulldowns were performed
three independent times, one with the DpdeA strain and twice with WT
L. monocytogenes.
Nucleotide-Binding Assays
The DRaCALA assays were performed with recombinant proteins or E. coli ly-
sates in binding buffer (40 mM Tris,100 mM NaCl, 20 mM MgCl2 [pH 7.5])
and analyzed as described previously (Roelofs et al., 2011). For competition
assays, 400 mM unlabeled nucleotide (ATP, GTP, cAMP, cGMP, NAD,
NADH, c-di-AMP, c-di-GMP, pApA) was added prior to the addition of
32P-c-di-AMP.
Protein Crystallization
LmPC crystals were grown by the sitting-drop vapor diffusion method at 20C.
For the c-di-AMP complex, the protein was incubated with 2.5 mM c-di-AMP
and 2.5 mM ATP for 30 min at 4C before setup. The reservoir solution con-
tained 19% (w/v) PEG3350 and 0.2 M ammonium citrate (pH 7.0). The crystals
appeared within 1–2 weeks and grew to full size after a few additional days.
The crystals were cryoprotected in the reservoir solution supplemented with
10% (v/v) PEG200 and were flash-frozen in liquid nitrogen for data collection
at 100 K. For the apo structure, the protein at 5 mg/ml was incubated with
2.5mMATP and 2.5mMpyruvate for 30min at 4Cbefore setup. The reservoir
solution contained 16% (w/v) PEG3350, 0.1 M Bis-Tris (pH 6.5), and 1% (w/v)
tacsimate (pH 7.0, Hampton). The crystals appeared within 1week and grew to
full size within a few more days. They were cryoprotected in the reservoir so-
lution supplemented with 15% (v/v) ethylene glycol and flash frozen in liquid
nitrogen. Data collection and structure determination were as detailed in the
Extended Experimental Procedures.
13C Incorporation Studies
Bacterial strains were grown overnight in BHI at 37C. The cells were sedi-
mented and washed with PBS. BHI was supplemented with 2.5 mg/ml
[U-13C6] glucose and were subsequently inoculated with an aliquot of the
cell suspensions to an OD600 of 0.1. The cultures were grown at 37
C until
OD600 = 1.0. Sodium azide was then added to a final concentration of
10 mM. The cells were centrifuged and washed three times with water. Bacte-
rial cells (approximately 20 mgwashed wet pellet) were suspended in 0.5 ml of
6 M hydrochloric acid. The mixture was heated at 105C for 24 hr. The hydro-
lysate was placed on a column of Dowex 50W3 8 (H+form; 200 to 400mesh; 5
by 10 mm) previously washed with 4 ml of 7% formic acid and water. After
loading the acid hydrolysate the column was washed with 4 ml of water. Sam-
ple was then eluted with 4 ml of 1 N ammonium hydroxide. The samples were
air-dried under vacuum, and the residue was dissolved in 30 ml of pyridine. A
total of 30 ml of-(tert-butyldimethyl-silyl)-methyl-trifluoroacetamide containing
1% tert-butyl-dimethyl-silylchloride (Sigma) was added. The mixture was kept
at 90C for 60 min. Derivatized amino acids were analyzed by GC/MS as
detailed in the Extended Experimental Procedures.
Tissue Culture and Infection Assays
Primary bone-marrow-derived macrophages were generated as previously
described (Jones and Portnoy, 1994). Macrophage growth curves, LDH, and
DNA release assays were performed in primary or J2 immortalized BMMs
(Sauer et al., 2010), as indicated. Plaque assays we conducted in L2 mouse
fibroblasts (Sun et al., 1990). Murine infections were performed as described
previously (Witte et al., 2013). All protocols were reviewed and approved by
the Institutional Animal Care and Use Committee at the University of Wiscon-
sin, Madison and the University of Washington.
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